Exposure Therapy Consortium (ETC) for Anxiety Sensitivity

NCT05225740 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 399

Last updated 2025-04-29

No results posted yet for this study

Summary

The current study seeks to test differences between a single-session large-group format of standard exposure, enhanced exposure, and a control condition in treating anxiety sensitivity. It is hypothesized that 1) participants assigned to either exposure condition will evidence greater reductions in anxiety sensitivity from pre-treatment to posttreatment relative to those in the control condition; 2) participants assigned to the enhanced exposure condition will evidence greater reductions in anxiety sensitivity from pre-treatment to posttreatment relative to those in the standard exposure condition. The investigators will test putative moderators and mechanisms of action. Prior to initiating the study for purposes of data analyses, the investigators will pilot study procedures during Spring 2020.

Conditions

  • Elevated Anxiety Sensitivity

Interventions

BEHAVIORAL

Standard Exposure

The standard intervention will include an orientation and psychoeducation phase, an exposure practice phase consisting five repeated trials per each of the three exposure exercises, and a post-exposure exercise. The post-exposure exercise will involve completing a set of questions regarding the exercises and the group experience.

BEHAVIORAL

Stress Management Training

Stress management training (SMT) is designed to help people better cope with feelings of anxiety that accompany high levels of anxiety sensitivity. SMT will involve group instruction in healthy ways to experience and cope with stress whenever difficult situations arise. Participants will teach participants ways to maintain a healthy lifestyle, targeting things like nutrition, exercise, and sleep hygiene. This intervention will also involve progressive muscle relaxation training.

BEHAVIORAL

Enhanced Exposure

The enhanced intervention will include an orientation and psychoeducation phase, an exposure practice phase consisting five repeated trials per each of the three exposure exercises, and a processing exercise. The post-processing exercise will involve completing a set of questions that will highlight harm expectancy violations.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    collaborator OTHER
  • University of Colorado, Boulder

    collaborator OTHER
  • University of Miami

    collaborator OTHER
  • University of Mississippi, Oxford

    collaborator OTHER
  • Ruhr University of Bochum

    collaborator OTHER
  • Boston University

    collaborator OTHER
  • Fordham University

    collaborator OTHER
  • The University of New South Wales

    collaborator OTHER
  • Southern Methodist University

    collaborator OTHER
  • Institute of Behavioral-Therapy and -Medicine at the Philipps University Marburg

    collaborator OTHER
  • Technische Universität Dresden

    collaborator OTHER
  • Curtin University

    collaborator OTHER
  • Hebrew University of Jerusalem

    collaborator OTHER
  • University of Göttingen

    collaborator OTHER
  • University of Texas at Austin

    lead OTHER

Principal Investigators

  • Jasper Smits, PhD · The University of Texas at Austin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • United States
  • Australia
  • Germany
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05225740 on ClinicalTrials.gov